07/26/2026
FARE is proud to join fellow medical and advocacy organizations in supporting DillonsLaw (H.R. 4564), a bipartisan effort led by Congressman Glenn Grothman and Rep. Debbie Dingell.
During anaphylaxis, epinephrine is the first-line treatment, and delays can have life-threatening consequences. Dillon's Law would encourage states to expand epinephrine training and empower trained individuals to administer lifesaving treatment during an allergic emergency. The bill would also recognize all FDA-approved epinephrine delivery systems, including newer options like nasal epinephrine.
Join us in urging Congress to advance Dillon's Law and help create safer schools and communities for everyone.
Learn more and take action: https://acofp.quorum.us/campaign/165274/